INVIA traveled to Madrid, Spain this past week to exhibit and attend the International Conference on Nuclear Cardiology and Cardiac CT (ICNC). The
international venue provided a platform for a variety of scientists and clinicians to exchange thoughts and new ideas. Attending and exhibiting at
ICNC was a great experience for INVIA to be able to meet and discuss Corridor4DM (4DM) with many of our international customers.
Dr. Edward Ficaro, president and co-founder of INVIA, was also requested to present at the international venue. His abstract “Quantitative identification
of sarcoidosis with FDG PET” won the award for the Best Regional Abstract for the United States.
The study shows a way to more effectively diagnose cardiac sarcoidosis (CS), an inflammatory disease that affects the heart.
In his study, PET/CT imaging was used to scan a set of patients injected with Rb-82 in addition to FDG. Corridor4DM algorithmically calculated Left Ventricular
surfaces for the Rb-82 images, and those surfaces were transferred onto the FDG images. By overlaying the two images with the CT data, deficiencies
within the left ventricular tissue were able to be accurately identified.
Using a pre-established control group of normal patients, he then determined the mean peak Standard Uptake Value (pSUV), the mean global SUV (mSUV), and
the coefficient of variation of global SUV (COV) for healthy hearts using quantitative methods based on 4DM’s SUV polar maps.
This data was then compared to data from the group of patients with known or suspected CS, and the pSUV threshold was determined to show good accuracy
for detection of CS. The study successfully determined a straightforward, semi-automated method for diagnosing cardiac sarcoidosis.
This method is being applied today, and allows for a faster and more accurate diagnosis of cardiac sarcoidosis.
Dr. James Corbett, co-founder of INVIA and head of Nuclear Cardiology at the University of Michigan, also presented at the international conference speaking
on “optimal patient selection and protocols for Cardiac PET.”
With INVIA’s attendance at ICNC, we are proud to share advancements in healthcare and strengthen our international relations. We look forward to our next
international conference and exhibition!